3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
8
Neoplasms
2
Squamous Non-small Cell Lung Cancer
1
Squamous Non Small Cell Lung Cancer
1
Solid Tumors
1
Solid Tumor, Adult
1
Neoplasm Metastasis
1
Colorectal Neoplasms
1
Carcinoma
1
Breast Neoplasms
1
Interventions
pembrolizumab
3
Ipilimumab
2
Blood Specimen Collection
2
spartalizumab
1
necitumumab
1
mirdametinib
1
leronlimab
1
apatinib
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Therapeutics
1
Surveys and Questionnaires
1
Rosuvastatin Calcium
1
Radiotherapy
1
Radiation
1
Positron-Emission Tomography
1
PankoMab-GEX
1
Panitumumab
1
Nivolumab
1
Metformin
1
Magnetic Resonance Imaging
1
MEK inhibitor I
1
Jupiter
1
JPT1 protein, human
1
Interleukin-2
1
Immune Checkpoint Inhibitors
1
GAT
1
Fluorodeoxyglucose F18
1
FCN-437c
1
EBI-005
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Solid Tumor, Adult
×
necitumumab
×
Clear all
NCT03360734
2021-07-12
GATTO
Glycotope GmbH
Phase 1
Completed
50 enrolled